Induction of GAP-43 modulates neuroplasticity in PBSC (CD34+) implanted-Parkinson's model

Journal of Neuroscience Research

Volumn 87, Issue 9, 2009, Pages 2020-2033

  Shyu, Woei Cherng ^a   Li, Kuo Wei ^a   Peng, Hsiao Fen ^a   Lin, Shinn Zong ^a   Liu, Ren Shyan ^b   Wang, Hsiao Jung ^b   Su, Ching Yuan ^c   Lee, Yih Jing ^d   Li, Hung ^b,c  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c INSTITUTE OF MOLECULAR BIOLOGY   (Taiwan)

^d FU JEN CATHOLIC UNIVERSITY   (Taiwan)

Author keywords

6 OHDA lesioning; 1H MRS; CD34; FDG PET; Growth associated protein 43 (GAP 43); Parkinson's disease; Peripheral blood stem cells

Indexed keywords

CD34 ANTIGEN; FLUORODEOXYGLUCOSE F 18; NEUROMODULIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN PROTECTION; CELLULAR DISTRIBUTION; CIRCLING BEHAVIOR; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; GLUCOSE METABOLISM; MALE; NERVE CELL PLASTICITY; NERVE REGENERATION; NEUROCHEMISTRY; NEUROTOXICITY; NONHUMAN; PARKINSON DISEASE; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTON NUCLEAR MAGNETIC RESONANCE; RAT; RECEPTOR UPREGULATION; TREATMENT RESPONSE;

ANIMALS; ANTIGENS, CD34; BIOLOGICAL MARKERS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CELL SURVIVAL; CORPUS STRIATUM; DENERVATION; DISEASE MODELS, ANIMAL; DOPAMINE; EXCITATORY AMINO ACID ANTAGONISTS; FLUORODEOXYGLUCOSE F18; GAP-43 PROTEIN; GLUCOSE; MALE; NEURONAL PLASTICITY; OXIDOPAMINE; PARKINSONIAN DISORDERS; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; POSITRON-EMISSION TOMOGRAPHY; RATS; RATS, SPRAGUE-DAWLEY; RECOVERY OF FUNCTION; STEM CELLS; SUBSTANTIA NIGRA;

EID: 65849526326     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.22027     Document Type: Article

References (38)

1. Aponso PM, Faull RL, Connor B. 2008. Increased progenitor cell proliferation and astrogenesis in the partial progressive 6-hydroxydopamine model of Parkinson's disease. Neuroscience 151:1142-1153.
2. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, Witzenbichler B, Schatteman G, Isner JM. 1997. Isolation of putative progenitor endothelial cells for angiogenesis. Science 275(5302):964-967.
3. Bachoud-Levi AC, Remy P, Nguyen JP, Brugieres P, Lefaucheur JP, Bourdet C, Baudic S, Gaura V, Maison P, Haddad B, Boisse MF, Grandmougin T, Jeny R, Bartolomeo P, Dalla Barba G, Degos JD, Lisovoski F, Ergis AM, Pailhous E, Cesaro P, Hantraye P, Peschanski M. 2000. Motor and cognitive improvements in patients with Huntington's disease after neural transplantation. Lancet 356(9246):1975-1979.
4. Benowitz LI, Routtenberg A. 1997. GAP-43: an intrinsic determinant of neuronal development and plasticity. Trends Neurosci 20:84-91.
5. Brownell AL, Chen YI, Yu M, Wang X, Dedeoglu A, Cicchetti F, Jenkins BG, Beal MF. 2004. 3-Nitropropionic acid-induced neurotoxicity assessed by ultra high resolution positron emission tomography with comparison to magnetic resonance spectroscopy. J Neurochem 89:1206-1214.
6. Cicchetti F, Brownell AL, Williams K, Chen YI, Livni E, Isacson O. 2002. Neuroinflammation of the nigrostriatal pathway during progressive 6-OHDA dopamine degeneration in rats monitored by immunohistochemistry and PET imaging. Eur J Neurosci 15:991-998.
7. Cotzias GC, Van Woert MH, Schiffer LM. 1967. Aromatic amino acids and modification of parkinsonism. N Engl J Med 276:374-379.
8. Damier P, Hirsch EC, Agid Y, Graybiel AM. 1999. The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease. Brain 122(Pt 8):1437-1448.
9. De Falco E, Porcelli D, Torella AR, Straino S, Iachininoto MG, Orlandi A, Truffa S, Biglioli P, Napolitano M, Capogrossi MC, Pesce M. 2004. SDF-1 involvement in endothelial phenotype and ischemia-induced recruitment of bone marrow progenitor cells. Blood 104: 3472-3482.
10. de Lau LM, Giesbergen PC, de Rijk MC, Hofman A, Koudstaal PJ, Breteler MM. 2004. Incidence of parkinsonism and Parkinson disease in a general population: the Rotterdam Study. Neurology 63:1240-1244.
11. Deacon T, Schumacher J, Dinsmore J, Thomas C, Palmer P, Kott S, Edge A, Penney D, Kassissieh S, Dempsey P, Isacson O. 1997. Histological evidence of fetal pig neural cell survival after transplantation into a patient with Parkinson's disease. Nat Med 3:350-353.
12. Elfenbein GJ, Sackstein R. 2004. Primed marrow for autologous and allogeneic transplantation: a review comparing primed marrow to mobilized blood and steady-state marrow. Exp Hematol 32:327-339.
13. Gash DM, Zhang Z, Ovadia A, Cass WA, Yi A, Simmerman L, Russell D, Martin D, Lapchak PA, Collins F, Hoffer BJ, Gerhardt GA. 1996. Functional recovery in parkinsonian monkeys treated with GDNF. Nature 380(6571):252-255.
14. Greely HT, Hamm T, Johnson R, Price CR, Weingarten R, Raffin T. 1989. The ethical use of human fetal tissue in medicine. Stanford University Medical Center Committee on Ethics. N Engl J Med 320: 1093-1096.
15. Hamacher K, Coenen HH, Stocklin G. 1986. Efficient stereospecific synthesis of no-carrier-added 2-[18F]-fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitution. J Nucl Med 27:235-238.
16. Hsu JY, Stein SA, Xu XM. 2005. Temporal and spatial distribution of growth-associated molecules and astroglial cells in the rat corticospinal tract during development. J Neurosci Res 80:330-340.
17. Ikegami T, Nakamura M, Yamane J, Katoh H, Okada S, Iwanami A, Watanabe K, Ishii K, Kato F, Fujita H, Takahashi T, Okano HJ, Toyama Y, Okano H. 2005. Chondroitinase ABC combined with neural stem/progenitor cell transplantation enhances graft cell migration and outgrowth of growth-associated protein-43-positive fibers after rat spinal cord injury. Eur J Neurosci 22:3036-3046.
18. Issa R, AlQteishat A, Mitsios N, Saka M, Krupinski J, Tarkowski E, Gaffney J, Slevin M, Kumar S, Kumar P. 2005. Expression of basic fibroblast growth factor mRNA and protein in the human brain following ischaemic stroke. Angiogenesis 8:53-62.
19. Kirik D, Breysse N, Bjorklund T, Besret L, Hantraye P. 2005. Imaging in cell-based therapy for neurodegenerative diseases. Eur J Nucl Med Mol Imaging 32(Suppl 2):S417-S434.
20. Kreis R, Ross BD, Farrow NA, Ackerman Z. 1992. Metabolic disorders of the brain in chronic hepatic encephalopathy detected with H-1 MR spectroscopy. Radiology 182:19-27.
21. Lu D, Margouleff C, Rubin E, Labar D, Schaul N, Ishikawa T, Kazumata K, Antonini A, Dhawan V, Hyman RA, Eidelberg D. 1997. Temporal lobe epilepsy: correlation of proton magnetic resonance spectroscopy and 18F-fluorodeoxyglucose positron emission tomography. Magn Reson Med 37:18-23.
22. Luo F, Liu X, Li S, Liu C, Wang Z. 2004. Melatonin promoted chemotaxins expression in lung epithelial cell stimulated with TNF-alpha. Respir Res 5:20.
23. Luque JM, Puig N, Martinez JM, Gonzalez-Garcia C, Cena V. 2001. Glutamate N-methyl-D-aspartate receptor blockade prevents induction of GAP-43 after focal ischemia in rats. Neurosci Lett 305:87-90.
24. Mani S, Schaefer J, Meiri KF. 2000. Targeted disruption of GAP-43 in P19 embryonal carcinoma cells inhibits neuronal differentiation. As well as acquisition of the morphological phenotype. Brain Res 853: 384-395.
25. Mani S, Shen Y, Schaefer J, Meiri KF. 2001. Failure to express GAP-43 during neurogenesis affects cell cycle regulation and differentiation of neural precursors and stimulates apoptosis of neurons. Mol Cell Neurosci 17:54-66.
26. Orlic D, Kajstura J, Chimenti S, Limana F, Jakoniuk I, Quaini F, Nadal-Ginard B, Bodine DM, Leri A, Anversa P. 2001. Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc Natl Acad Sci USA 98:10344-10349.
27. Perovic M, Mladenovic A, Rakic L, Ruzdijic S, Kanazir S. 2005. Increase of GAP-43 in the rat cerebellum following unilateral striatal 6-OHDA lesion. Synapse 56:170-174.
28. Saunders DE, Howe FA, van den Boogaart A, McLean MA, Griffiths JR, Brown MM. 1995. Continuing ischemic damage after acute middle cerebral artery infarction in humans demonstrated by short-echo proton spectroscopy. Stroke 26:1007-1013.
29. Schmidt RH, Bjorklund A, Stenevi U, Dunnett SB, Gage FH. 1983. Intra-cerebral grafting of neuronal cell suspensions. III. Activity of intrastriatal nigral suspension implants as assessed by measurements of dopamine synthesis and metabolism. Acta Physiol Scand Suppl 522:19-28.
30. Shyu WC, Lin SZ, Saeki K, Kubosaki A, Matsumoto Y, Onodera T, Chiang MF, Thajeb P, Li H. 2004. Hyperbaric oxygen enhances the expression of prion protein and heat shock protein 70 in a mouse neuroblastoma cell line. Cell Mol Neurobiol 24:257-268.
31. Sigurjonsson OE, Perreault MC, Egeland T, Glover JC. 2005. Adult human hematopoietic stem cells produce neurons efficiently in the regenerating chicken embryo spinal cord. Proc Natl Acad Sci USA 102:5227-5232.
32. Stumm RK, Rummel J, Junker V, Culmsee C, Pfeiffer M, Krieglstein J, Hollt V, Schulz S. 2002. A dual role for the SDF-1/CXCR4 chemokine receptor system in adult brain: isoform-selective regulation of SDF-1 expression modulates CXCR4-dependent neuronal plasticity and cerebral leukocyte recruitment after focal ischemia. J Neurosci 22: 5865-5878.
33. van Dam EJ, Ruiter B, Kamal A, Ramakers GM, Gispen WH, de Graan PN. 2002. N-methyl-D-aspartate-induced long-term depression is associated with a decrease in postsynaptic protein kinase C substrate phosphorylation in rat hippocampal slices. Neurosci Lett 320:129-132.
34. Visnyei K, Tatsukawa KJ, Erickson RI, Simonian S, Oknaian N, Carmichael ST, Kornblum HI. 2006. Neural progenitor implantation restores metabolic deficits in the brain following striatal quinolinic acid lesion. Exp Neurol 197:465-474.
35. Wang Y, Chang CF, Morales M, Chiang YH, Harvey BK, Su TP, Tsao LI, Chen S, Thiemermann C. 2003. Diadenosine tetraphosphate protects against injuries induced by ischemia and 6-hydroxydopamine in rat brain. J Neurosci 23:7958-7965.
36. West MJ. 1993. New stereological methods for counting neurons. Neurobiol Aging 14:275-285.
37. Wu DC, Jackson-Lewis V, Vila M, Tieu K, Teismann P, Vadseth C, Choi DK, Ischiropoulos H, Przedborski S. 2002. Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson disease. J Neurosci 22:1763-1771.
38. Zhang RL, Zhang ZG, Zhang L, Chopp M. 2001. Proliferation and differentiation of progenitor cells in the cortex and the subventricular zone in the adult rat after focal cerebral ischemia. Neuroscience 105: 33-41.